Update on Glenmark’s Recall of Potassium Chloride Extended-Release Capsules

The Block Firm’s investigation continues into Glenmark’s recall of tens of millions of potassium chloride extended-release capsules. Here is what we have learned so far and what The Block Firm is doing about it. What is the Glenmark recall? Glenmark Pharmaceuticals has recalled approximately 90 million capsules of potassium chloride extended-release due to a safety…

Read More

The Block Firm Files Class Action Lawsuit Against Glenmark Pharmaceuticals

At The Block Firm, we are committed to holding drug companies accountable when they prioritize profits over patient safety. We recently filed a class action lawsuit against Glenmark Pharmaceuticals, Inc. for the company’s failure to meet essential safety standards for Potassium Chloride Extended-Release Capsules. (read complaint here) The Issue: Dangerous Drug Practices Potassium chloride is…

Read More

Glenmark Drug Recall: Potassium Chloride Extended Release Capsules

On June 24, 2024, the FDA published a recall of certain batches of Glenmark Pharmaceuticals’ Potassium Chloride Extended Release Capsules because they failed to meet the required dissolution specifications. According to the FDA, due to this defect, the “capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat that…

Read More

Understanding Class Action Lawsuits: What You Need to Know

If you’ve ever heard about class action lawsuits but weren’t quite sure what they entailed, you’re not alone. These legal actions can seem complex, but they play a crucial role in our justice system. At The Block Firm in Atlanta, we specialize in class action lawsuits, and we’re here to break down what they are,…

Read More

Victory for Main Street Burger in Lease Renewal Dispute

The Block Firm is thrilled to announce a significant legal victory for our client, Main Street Burger, Inc., in their recent appellate case against the Estate of David W. Collier and associated parties. This decision marks a pivotal moment in a prolonged lease dispute involving the revitalization efforts of the Kennesaw Downtown Development Authority (KDDA)…

Read More

Breckenridge Duloxetine Recall Expands—Now Approximately 70 Million Pills

As The Block Firm previously revealed, Breckenridge Pharmaceutical, Inc. has recalled at least 50 million tablets of Duloxetine due to the presence of nitrosamines, potent carcinogens, in excess of FDA levels. As a result, The Block Firm filed a class action on behalf of Duloxetine patients, seeking to hold Breckenridge accountable for selling adulterated drugs.…

Read More

Court Grants Final Approval to $46.5 Million Class Action Settlement

This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The settlement, in the case of Faulkner v. Acella Pharmaceuticals (N.D. Ga.), resolves allegations that a drugmaker sold a defective thyroid medication on the basis of false advertising about the drug’s active ingredient.…

Read More

The Block Firm Files Class Action About Contaminated Drugs

This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of a generic form of Cymbalta (duloxetine). The defendant, Breckenridge Pharmaceutical, Inc., recalled more than 50 million pills because they were contaminated with nitrosamines. Nitrosamines are a known byproduct of unsafe…

Read More

Attorney Max Marks Argues on behalf of Fitzgerald Fruit Farms in front of the Supreme Court of Georgia in Case Whitaker Farms LLC vs. Fitzgerald Farms LLC

On May 16, 2024 Max Marks argued on behalf of Fitzgerald Farms in front of the Supreme Court of Georgia, defending his victories at trial and before the court of appeals in Whitaker Farms, LLC vs. Fitzgerald Farms LLC, No. s23G1162. In that case, Max represents a family farmer whose crops were destroyed as a result of what two…

Read More